COMMUNIQUÉS West-GlobeNewswire

Aduro Biotech to Host Investor Event Featuring ADU-S100 (MIW815) Clinical Data Presented at the 2019 American Society of Clinical Oncology Annual Meeting
15/05/2019
BERKELEY, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]
Aduro Biotech Announces Clinical Program Update for Anti-APRIL Antibody BION-1301
15/05/2019
First healthy volunteer cohort cleared in Phase 1 first-in-human study of BION-1301 for the treatment of IgA nephropathy (IgAN); initial data in healthy volunteers expected in H1 2020 and IgAN patients in H2 2020 [...]
Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
15/05/2019
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Micron Solutions, Inc. Reports 2019 First Quarter Results
15/05/2019
FITCHBURG, Mich., May 15, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Forty Seven, Inc. to Present Initial Safety and Efficacy Data from Phase 1b Clinical Trial of 5F9 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome at 2019 ASCO Annual Meeting
15/05/2019
-- Forty Seven to Host Investor Event and Webcast on June 3, 2019 -- -- Forty Seven Management to Participate in MATTER Panel, The Current and Future Wave of Immuno-Oncology Therapies, on May 30, 2019 -- MENLO PARK, [...]
Cybrexa Therapeutics’ Preclinical Data Demonstrate its alphalex™ Platform Enables Tumor Targeting of Multiple PARP Inhibitors, Effectively Inducing Significant Tumor Cell Killing When Combined with Chemotherapy
15/05/2019
Results support the potential of alphalex™ technology with diverse range of anticancer agents Targets HRD-negative cancers, while avoiding significant bone marrow toxicity typically induced when PARP inhibitors are [...]
Oncternal Therapeutics to Present Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib at the 2019 American Society of Clinical Oncology Annual Meeting
15/05/2019
SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., a clinical-stage biotechnology company focused on developing potential first-in-class therapeutic candidates for cancers with critical unmet [...]
Y-mAbs Announces Data to be Presented at 2019 ASCO Annual Meeting
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc., (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Harvard Bioscience Subsidiary Data Sciences International Launches Digital Telemetry Implant for Measuring Respiratory Endpoints
15/05/2019
Digital Telemetry Implant Saves Researchers Time and Money by Collecting More Data From One Implant ST. PAUL, Minn. and HOLLISTON, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary [...]
ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock
15/05/2019
RAMSEY, N.J. and BOCA RATON, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company [...]
EDAP Reports 2019 First Quarter Results
15/05/2019
EDAP Reports 2019 First Quarter Results HIFU revenue growth of 58.6% year-over-year Profitable for second consecutive quarter Total Q1 revenues of EUR 10.1 million; strongest Q1 to date Improved Q1 gross profit margin [...]
SELLAS Life Sciences Provides Business Update and Reports First Quarter 2019 Financial Results
15/05/2019
Company to Present Data at Upcoming American Society of Clinical Oncology (ASCO) Annual Meeting NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a [...]
Precision Optics Corporation, Inc. Announces Operating Results for the Third Quarter and Nine Months of Fiscal Year 2019
15/05/2019
GARDNER, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced operating results on an unaudited basis for its fiscal year 2019 third quarter and nine [...]
Auris Medical Announces Closing of Public Offering of Common Shares
15/05/2019
Hamilton, Bermuda, May 15, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
The Cooper Companies to Present at Jefferies Healthcare Conference
15/05/2019
PLEASANTON, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the Jefferies Healthcare Conference in New York, NY, on June 4, 2019. Brian G. Andrews, Senior Vice President, [...]
Spine Injury Solutions Announces Results for the Fiscal First Quarter Ended March 31, 2019
15/05/2019
HOUSTON, May 15, 2019 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN) today announced financial results for its Fiscal 2019 first quarter ended March 31, 2019. Financial Highlights Revenues for the quarter [...]
Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
15/05/2019
Management to Host Conference Call to Review Financial Results and Provide Corporate Update at 4:30PM Today MINNEAPOLIS, May 15, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the [...]
Agios to Present Clinical Data from its IDH Program at ASCO
15/05/2019
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that data from its [...]
Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting
15/05/2019
Preliminary results from patients treated with BPX-601 who underwent lymphodepletion with cyclophosphamide plus fludarabine to be presented HOUSTON, May 15, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. ( [...]

Pages